Thermo Fisher Scientific said that at its Annual Meeting held on May 22, 2024, nominees including Marc N. Casper were elected to the Board of Directors for a 1-year term expiring at the 2025 annual meeting of shareholders.

1. 01

   Thermo Fisher Scientific said that at its Annual Meeting held on May 22, 2024, nominees including Marc N. Casper were elected to the Board of Directors for a 1-year term expiring at the 2025 annual meeting of shareholders.

2. 02

   The company reported that director nominee Marc N. Casper received 291,642,341 votes for, 26,264,880 against, 1,251,106 abstentions and 18,939,070 broker non-votes.

3. 03

   The company said the non-binding advisory proposal on the compensation of its named executive officers was approved with 280,838,866 votes for and 35,306,239 against, and the appointment of PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending December 31, 2024 was approved with 300,707,160 votes for and 36,959,440 against.

4. 04

   The company reported that the shareholder proposal to implement simple majority voting was not approved, with 21,434,413 votes for, 296,785,778 against and 938,136 abstentions.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.